	US 11,926,846 B2
	Hydroxyurea to enhance sperm cells
Anthony Archibong, Antioch, TN (US); James Hildreth, Nashville, TN (US); Letitia Lyons, Houston, TX (US); and Shannon Roberson, Smyrna, TN (US)
Assigned to Meharry Medical College, Nashville, TN (US)
Filed by Meharry Medical College, Nashville, TN (US)
Filed on Nov. 7, 2019, as Appl. No. 16/677,542.
Application 16/677,542 is a continuation of application No. PCT/US2018/031659, filed on May 8, 2018.
Claims priority of provisional application 62/503,131, filed on May 8, 2017.
Prior Publication US 2020/0087619 A1, Mar. 19, 2020
Int. Cl. A61K 35/52 (2015.01); A01N 1/02 (2006.01); C12N 5/076 (2010.01)

CPC C12N 5/061 (2013.01) [A01N 1/0221 (2013.01); A61K 35/52 (2013.01)]

10 Claims

1. A method of enhancing sperm motility, comprising:

providing a spermatozoon, and

contacting the spermatozoon with a composition comprising an effective amount of hydroxyurea.